Status:
RECRUITING
Impact of Neuropsychological Disorders in Multiple Sclerosis
Lead Sponsor:
Lille Catholic University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The study involves MS patients with and without neuropsychological disorders. The patient will benefit from: * A routine neuropsychological assessment, including a cognitive and emotional assessment...
Eligibility Criteria
Inclusion
- Understanding and able to speak French
- Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS \<4
- No significant motor, cerebellar or somesthesia disorders of the upper limbs or visual disturbances (side to a visual EDSS \<2)
- Absence of corticosteroid intake in the last four weeks
- Benefiting from health insurance coverage
- Not showing any flare-ups or worsening of the disease in the last 6 weeks
- No botulinum toxin injection for more than 4 months
Exclusion
- People with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general ailments, perceptual or dysarthric disorders preventing verbal communication or reading,
- Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
- Refusal to participate after clear and fair information about the study.
- Adults under tutorship, curatorship or safeguard of justice
- With orthopedic treatment influencing walking
- Pregnant woman
Key Trial Info
Start Date :
May 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04837365
Start Date
May 21 2021
End Date
May 1 2026
Last Update
September 4 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
St Vincent hospital - neurological service
Lille, France
2
St Philibert hospital - Neurologial service
Lomme, France
3
St Philibert hospital - Physical Medicine and Rehabilitation
Lomme, France